Dr. Robert H Cinatl, DDS Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 1019 Ghaner Rd, Suite 100, Port Matilda, PA 16870 Phone: 814-238-7120 |
Dr. G. Matthew Kremser, DMD Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 1019 Ghaner Rd Ste A, Port Matilda, PA 16870 Phone: 814-238-7120 Fax: 814-238-2981 |
Dr. Robert L Kilareski, DDS Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 1019 Ghaner Rd Ste A, Port Matilda, PA 16870 Phone: 814-238-7120 Fax: 814-238-2981 |
Dr. Jason Rea Stetson, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1019 Ghaner Rd, Port Matilda, PA 16870 Phone: 814-308-0954 Fax: 814-954-7370 |
Dr. Jonathan Henry Kremser, D.D.S Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 1019 Ghaner Rd Ste A, Port Matilda, PA 16870 Phone: 814-238-7120 Fax: 814-239-2981 |
Dr. John R Kelly, DDS Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 1019 Ghaner Rd Ste A, Port Matilda, PA 16870 Phone: 814-238-7120 Fax: 814-238-2981 |
Dr. Kevin James Dincher, D.M.D. Dentist - Dentist Anesthesiologist Medicare: Not Enrolled in Medicare Practice Location: 1019 Ghaner Rd, Port Matilda, PA 16870 Phone: 570-772-2506 |
Dr. Chase Daniel Ellis, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1019 Ghaner Rd Ste 100, Port Matilda, PA 16870 Phone: 814-238-7120 Fax: 814-238-2981 |
News Archive
Specially designed nanoparticles can reveal tiny cancerous tumors that are invisible by ordinary means of detection, according to a study by researchers at Washington University School of Medicine in St. Louis.
A new study shows that a new type of targeted radiation therapy called stereotactic radiation therapy is just as good as surgery for patients aged 75 and older with early-stage lung cancer, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and the University of Chicago.
Idera Pharmaceuticals, Inc. today announced positive interim results from a Phase 1 clinical trial of IMO-2125 in patients with chronic hepatitis C virus infection (HCV). IMO-2125 is an agonist of Toll-like Receptor 9 that Idera designed to treat HCV by inducing endogenous interferon-alpha and other Th1-type cytokines and chemokines.
Fluorescence-based biosensing and bioimaging technologies are widely used in research and clinical settings to detect and image various biological species of interest.
Various plants and their products are known to contain "bioactive" ingredients that can alleviate human diseases. These "phytocompounds" often contain restorative biological properties such as anti-cancerous, antioxidant, and anti-inflammatory effects.
› Verified 4 days ago